Medical journal, Armed Forces India · 2023
Resveratrol as an add on therapy to sertraline in animal models of depression.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mohan Prafull, Avinash K, Arun J, Mishra Prashant, Sinha Sharmila
Аннотация
BACKGROUND: Sertraline, a selective serotonin reuptake inhibitor, is a leading antidepressant. Resveratrol is a natural polyphenol with diverse biological activities, including antidepressant-like effects. In this study we evaluated the individual and combined antidepressant effects of resveratrol and sertraline alongwith effect of resveratrol on sertraline serum levels.
METHODS: Tail Suspension Test (TST) and Forced Swim Test (FST) were used to study the antidepressant effect in adult male albino mice which were divided into 5 groups. Group 1 was treated with sertraline, group 2 with resveratrol, group 3 and 4 with sertraline (different doses) and resveratrol, and group 5 was given vehicle control only. Serum sertraline levels were estimated by high performance liquid chromatography (HPLC). Mean increase in time to immobility in TST and mean reduction in immobility in FST of the animal(s) were compared.
RESULTS: Combination of sertraline and resveratrol demonstrated the maximum antidepressant effect followed by sertraline and resveratrol only groups. Serum sertraline levels were higher in the combination group as compared to sertraline only group.
CONCLUSION: Resveratrol demonstrated antidepressant effects in this study and also had an additive effect on the effect of sertraline. It's addition also increased serum sertraline levels.
METHODS: Tail Suspension Test (TST) and Forced Swim Test (FST) were used to study the antidepressant effect in adult male albino mice which were divided into 5 groups. Group 1 was treated with sertraline, group 2 with resveratrol, group 3 and 4 with sertraline (different doses) and resveratrol, and group 5 was given vehicle control only. Serum sertraline levels were estimated by high performance liquid chromatography (HPLC). Mean increase in time to immobility in TST and mean reduction in immobility in FST of the animal(s) were compared.
RESULTS: Combination of sertraline and resveratrol demonstrated the maximum antidepressant effect followed by sertraline and resveratrol only groups. Serum sertraline levels were higher in the combination group as compared to sertraline only group.
CONCLUSION: Resveratrol demonstrated antidepressant effects in this study and also had an additive effect on the effect of sertraline. It's addition also increased serum sertraline levels.